Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL5555109

Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
Cc1cc([C@H](C(=O)N2C[C@H](S(=O)(=O)F)C[C@H]2C(=O)N[C@@H](CC(=O)N2CCC(C#Cc3ccc(C(=O)N[C@H]4C(C)(C)[C@H](Oc5ccc(C#N)c(Cl)c5)C4(C)C)cc3)CC2)c2ccc(-c3scnc3C)cc2)C(C)C)on1

Basic Information

ChEMBL ID CHEMBL5555109
Phase Preclinical
Structure Type MOL
InChI Key YVXTYEKDOUWSSR-AYXOQTJASA-N
1
Targets
1
Activities
1
Assay Types
0
PK Parameters
3
Publications
0
Known Names

Molecular Properties

1078.7
MW (Da)

Drug Information

Availability Unknown
Chirality Unknown

Flags

First in Class Prodrug

Extended Properties

Molecular Formula C56H61ClFN7O8S2
MW 1078.73

Activity Summary

EC50 1 meas. best 6.67

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
von Hippel-Lindau disease tumor suppressor/Androgen receptor
CHEMBL4523730
EC50 6.67 6.67 212.0 1

Activity Data Samples

Top measurements by pChEMBL value

Literature References

PubMed DOI Target Context # Activities
38478885 10.1021/acs.jmedchem.3c02123 von Hippel-Lindau disease tumor suppressor/Androgen receptor 4
38199162 10.1016/j.ejmech.2023.116041 von Hippel-Lindau disease tumor suppressor/Androgen receptor 2
38478885 10.1021/acs.jmedchem.3c02123 LNCaP 1

Data from ChEMBL 36 via Core Engine